Dr. Aaron D. Bleznak, MD

Dr. Bleznak practices at Physicians' Surgery Center, Lancaster General Health in Lancaster, Pennsylvania.

Dr. Bleznak's NPI, 1619984242, was assigned on August 3, 2006. Dr. Bleznak graduated from Sidney Kimmel Medical College in 1983. Dr. Bleznak holds Virginia license 0101250542.

Dr. Bleznak's primary practice is Physicians' Surgery Center, Lancaster General Health, at 2150 Harrisburg Pike, Lancaster, PA 17604. The practice phone is (717) 735-3993.

Dr. Bleznak's primary practice is Physicians' Surgery Center, Lancaster General Health in Lancaster, Pennsylvania. Dr. Bleznak is also affiliated with Riverside Regional Medical Center. The medical group on file is Penn Medicine Lancaster General Health Physicians, Behavioral Health. Dmand AI also links Dr. Bleznak to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bleznak practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Bleznak's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Bleznak is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Bleznak's licenses on file in 2 states: Virginia and Pennsylvania.

Dmand AI lists breast surgery and mastectomy among the conditions Dr. Bleznak treats.

CMS data shows 155 Medicare services from Dr. Bleznak across 7 procedure codes in 2024, for 67 Medicare patients. Medicare paid $28,646 for them.

CMS counts 67 Medicare patients who saw Dr. Bleznak in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bleznak's median patient age at 61, with 99% women.

In 2024, Dr. Bleznak wrote 43 Medicare Part D claims for 18 patients. 100% of them were for generic drugs. CMS names the drug for 27 of them, across 1 drug with 11 or more claims each, at $342 in total drug cost. In 2023, CMS named 87 claims across 3 drugs.

Dr. Bleznak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 43 procedures of mastectomy by Dr. Bleznak, more than 92% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Bleznak, published from 2009 to 2025. 2011 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Delivery of Health Care and Mastectomy. Dr. Bleznak has published most often in Ann Surg Oncol. Dr. Bleznak's most frequent co-authors are Parag Bharadwaj, MD, Lisa Bailey, MD and Kelley Chan.

CMS Open Payments shows 7 general payments to Dr. Bleznak from 7 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 62% of the total. ZOLL Medical Corporation paid the most, $280.

Dmand AI lists 6 awards for Dr. Bleznak, most recently Top Doctors in 2023. Dr. Bleznak serves on Accreditation Committee Commission on Cancer, Commission on Cancer and National Accreditation Program for Breast Centers.

Dr. Bleznak graduated from Sidney Kimmel Medical College in 1983. Dr. Bleznak is a member of AAPL, ACS, ASBS and SSO.

Dr. Bleznak is in network with 18 carriers, including United Healthcare, Cigna and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.